ROS-responsive resiquimod prodrug nanoparticles for macrophage reprogramming and enhanced immune checkpoint inhibitor therapy in bladder cancer
Rui Geng, Haojie Shang, Zhiqiang Chen, Kun Tang, Yijing Liu, Jintao Zhu
Topics & Concepts
Cancer researchReprogrammingProdrugMaterials scienceMacrophageCancer immunotherapyImmune checkpointCancer therapyCancerImmunotherapyPharmacologyMedicineCellInternal medicineChemistryBiochemistryIn vitroImmune cells in cancerBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers